semaglutide and tirzepatide compounding pharmacy title π¨ Important Update on Compounded GLP-1 Injectables π¨ The FDA has announced that the shortage is resolved, requiring all 503A pharmacies to stop dispensing injectable semaglutide by April Ozempic | Semaglutide | Weight
Description
You can, but go easy
This means that pharmacies can no longer make or distribute tirzepatide in the form that many patients have been using for years
Each comes in a pre-filled pen that is simple to use
In practice, most clinicians would likely taper tirzepatide down before initiating retatrutide to manage overlapping GI side effects and assess the new compound's individual response
Trusted websites like Healthon are good places to stay updated on the latest drug administration news and FDA regulations for compounded medications
